Annual Total Liabilities
$17.56 M
+$4.61 M+35.56%
December 31, 2023
Summary
- As of February 8, 2025, IOBT annual total liabilities is $17.56 million, with the most recent change of +$4.61 million (+35.56%) on December 31, 2023.
- During the last 3 years, IOBT annual total liabilities has fallen by -$23.40 million (-57.13%).
- IOBT annual total liabilities is now -57.13% below its all-time high of $40.96 million, reached on December 31, 2020.
Performance
IOBT Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$17.38 M
+$2.19 M+14.38%
September 30, 2024
Summary
- As of February 8, 2025, IOBT quarterly total liabilities is $17.38 million, with the most recent change of +$2.19 million (+14.38%) on September 30, 2024.
- Over the past year, IOBT quarterly total liabilities has increased by +$4.69 million (+36.93%).
- IOBT quarterly total liabilities is now -77.39% below its all-time high of $76.86 million, reached on June 30, 2021.
Performance
IOBT Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
IOBT Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +35.6% | +36.9% |
3 y3 years | -57.1% | +36.9% |
5 y5 years | -46.7% | +36.9% |
IOBT Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +69.4% | -1.0% | +105.0% |
5 y | 5-year | -57.1% | +69.4% | -77.4% | +105.0% |
alltime | all time | -57.1% | +69.4% | -77.4% | +105.0% |
IO Biotech Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $17.38 M(+14.4%) |
Jun 2024 | - | $15.20 M(+19.7%) |
Mar 2024 | - | $12.69 M(-27.7%) |
Dec 2023 | $17.56 M(+35.6%) | $17.56 M(+17.3%) |
Sep 2023 | - | $14.96 M(+14.8%) |
Jun 2023 | - | $13.04 M(+3.2%) |
Mar 2023 | - | $12.63 M(-2.5%) |
Dec 2022 | $12.95 M | $12.95 M(+49.4%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $8.67 M(-17.2%) |
Jun 2022 | - | $10.47 M(+23.5%) |
Mar 2022 | - | $8.48 M(-18.2%) |
Dec 2021 | $10.36 M(-74.7%) | $10.36 M(-85.5%) |
Sep 2021 | - | $71.69 M(-6.7%) |
Jun 2021 | - | $76.86 M(+87.7%) |
Dec 2020 | $40.96 M(+24.3%) | $40.96 M |
Dec 2019 | $32.95 M | - |
FAQ
- What is IO Biotech annual total liabilities?
- What is the all time high annual total liabilities for IO Biotech?
- What is IO Biotech annual total liabilities year-on-year change?
- What is IO Biotech quarterly total liabilities?
- What is the all time high quarterly total liabilities for IO Biotech?
- What is IO Biotech quarterly total liabilities year-on-year change?
What is IO Biotech annual total liabilities?
The current annual total liabilities of IOBT is $17.56 M
What is the all time high annual total liabilities for IO Biotech?
IO Biotech all-time high annual total liabilities is $40.96 M
What is IO Biotech annual total liabilities year-on-year change?
Over the past year, IOBT annual total liabilities has changed by +$4.61 M (+35.56%)
What is IO Biotech quarterly total liabilities?
The current quarterly total liabilities of IOBT is $17.38 M
What is the all time high quarterly total liabilities for IO Biotech?
IO Biotech all-time high quarterly total liabilities is $76.86 M
What is IO Biotech quarterly total liabilities year-on-year change?
Over the past year, IOBT quarterly total liabilities has changed by +$4.69 M (+36.93%)